A Q&A With Shauna Applin, ARNP. AJMC: Despite substantial therapeutic advances since the 1980s, the US is not on pace to achieve the goals of the Ending the HIV Epidemic (EHE) public health initiative ...

Despite highly effective HIV prevention drugs on the market, only a fraction of those at risk in the U.S. are taking them — or even know they're an option. It's called pre-exposure prophylaxis, or ...

In the United States, HIV continues to be a significant cause of morbidity and mortality. In 2023, more than 39,000 people were diagnosed with HIV, and approximately 4,500 people died from causes ...

In recent years, the story around HIV has shifted dramatically. What was once viewed as a life sentence is now increasingly seen as a manageable condition. Medication is responsible for much of that ...

Yeztugo (lenacapavir) is more than 99.9 percent effective at protecting at-risk people from HIV — but for many, accessing the drug may be a challenge. Yeztugo (lenacapavir) is the first and only ...

RICHMOND, Va. (WRIC) — A new manufacturing process is on track to make developing HIV-prevention medication more affordable and potentially decrease new HIV infections in hard-hit countries. Virginia ...

By Ben Ezeamalu and Jennifer Rigby MAKURDI, Nigeria, March 31 (Reuters) - For several months last year, Josephine Angev ...

HIV PREVENTION. BETHEL. >> YEAH, SO. >> THIS ISN’T JUST ABOUT MEDICINE. THIS IS ABOUT CONFIDENCE CONTROL AND PROTECTION. I TALKED TO A LOCAL ADVOCATE WHO’S LIVING WITH HIV AND PROUDLY OWNING HER STORY ...

Advocates warn reductions to drug access, eligibility and provider contracts could disrupt care for thousands across South ...

The US is reportedly leveraging health aid to gain access to Zambia's critical minerals. Millions depend on US funding for HIV, tuberculosis, and malaria treatment. Yet Zambia is hesitant to agree.